In past weeks, we have seen extraordinary efforts by cancer health professionals, seeking to do their utmost to provide care and support for patients. I would like to thank you for your commitment in the face of COVID-19 events, and for your support for people who are undergoing cancer treatment within the greater ripple of a global pandemic.
Cancer alliances on both sides of the Yarra are working together to face the COVID-19 pandemic by providing support and advice to clinicians and health care services treating patients with cancer.
The VCCC Teletrial Program has developed functional teletrial standard operating procedures that can be directly applied to any clinical trial unit in Victoria.
Although the underlying Bayesian theoretical concepts were first developed almost 250 years ago, they were not used much until the last two decades. For most real-world problems, we had to wait until computers were powerful enough to apply them.
Adolescents can develop adult-type cancers but are often excluded from participation in clinical trials due to their age. The VCCC is working with Australia's Therapeutic Goods Administration to alleviate this significant access barrier.
Associate Professor Elwood is the recipient of a $12,000 scholarship to undertake the Leading for Organisational Impact: The Looking Glass Experience program at the Melbourne Business School (MBS).
Supportive Care and Palliative Care has been incorporated into the Master of Cancer Sciences program; to commence in Term 2 starting on 20 April. Course convenor Dr David Kok spoke with the presenters of the new subject - and was also featured in a podcast with Dr Dan Grant, CEO of MTPConnect this week.
Amanda Oliver was a Picchi Award winner in 2019 and travelled to the United Kingdom and France as part of her prize. We are currently seeking applications for this year's award.
The Primary Care Collaborative Cancer Clinical Trials Group (PC4) is based at the University of Melbourne Centre for Cancer Research (UMCCR). They are seeking to identify what the top research priorities should be in the field of cancer in primary care research.
The value of clinical registries to provide insight into real-world treatment patterns has been acknowledged and demonstrated, but there is additional potential for such registries to inform health economic evaluations of cancer treatments and support future treatment decisions.
